Always consult a qualified healthcare professional before starting, stopping, changing, or combining medications or treatment plans.
doi:10.2337/db19-54-OR 44
If the risk of hypoglycaemia is high, the same classes of agents and a dipeptidyl peptidase 4 (DPP-4) inhibitor or a peroxisome proliferator-activated receptors (PPAR-) agonist should be considered
Lose an average of 16.6% of your body weight in 64 weeks (1 year, 3 months) Starting at $149 Lose an average of 22.5% of your body weight in 72 weeks (1 year, 5 months) Starting at $299 Lose an average of 12.4% of your body weight in 72 weeks (1 year, 5 months) Starting at $149 The pricing provided is an estimate only and is not final
There has been an explosion in popularity of unregulated injectable peptides in Australia, with social media users creating content about their supposed benefits and how to buy and use them
Age, baseline health status, concurrent medications, and individual health goals all factor into clinical determinations